Ovarian reserve after three‐step laparoscopic surgery for endometriomas utilizing dienogest: A pilot study
article
OA: gold
CC0
⤵ 14 in-corpus citations
Abstract
Abstract Purpose Surgery for endometriomas may cause detrimental effects on ovarian reserve. We evaluated the safety of three‐step laparoscopic surgery for endometriomas utilizing dienogest in terms of post‐surgical ovarian reserve. Methods Twelve women received first look laparoscopy (FLL) with fenestration and drainage. Immediately after the surgery, they took oral dienogest 2 mg for three months; then, they received second look laparoscopy (SLL) with cystectomy. We compared serum AMH levels between women had three‐step management with dienogest, and another twelve women had conventional one‐step surgery without medications. In women had three‐step procedures, the changes in concentration of proinflammatory cytokines and chemokines in peritoneal fluids were evaluated. Results Serum AMH levels were significantly decreased after three months of dienogest following FLL. AMH levels were also significantly decreased 3‐6 months both after SLL and after one‐step surgery; however, recovery of serum AMH levels at 9‐12 months after surgery was evident in women had three‐step surgery comparing to those of one‐step surgery. Proinflammatory cytokines and chemokines in peritoneal fluids were downregulated at the time of SLL comparing to those of FLL. Conclusions Three‐step surgery with dienogest may be a beneficial approach to protect ovarian reserve. Dienogest may exert its effects in part by lowering proinflammatory cytokines and chemokines.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- Can chemokines be used as biomarkers for endometriosis? A systematic review via openalex
- Dienogest: A New Therapeutic Agent for the Treatment of Endometriosis via openalex
- Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells via openalex
- Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery? via openalex
- Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis via openalex
- Endometriosis surgery and preservation of fertility, what surgeons should know via openalex
- Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells via openalex
- Large ovarian endometriomas via openalex
- One-year follow-up of serum antimüllerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve? via openalex
- Ovarian reserve after three‐step laparoscopic surgery for endometriomas utilizing dienogest: A pilot study via openalex
- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities via openalex
- Progesterone resistance in endometriosis: origins, consequences and interventions via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Short-term histopathological effects of dienogest therapy on ovarian endometriomas: <i>in vivo</i>, nonrandomized, controlled trial via openalex
- Surgical arrows should be identified on the cyst wall via openalex
- Surgical treatment of ovarian endometriomas: state of the art? via openalex
- The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study via openalex
- The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study via openalex
- W1966488004 via openalex
- W2113809944 via openalex
- W2996101359 via openalex
- W2163315477 via openalex
Cited by (14)
- Ovarian reserve after dienogest therapy versus laparoscopic cystectomy for unilateral endometriomas: A randomized clinical trial 2024
- Endometrioma surgery: Hit with your best shot (But know when to stop) 2024
- Perioperative hormone treatment of endometriosis 2023
- Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes 2023
- Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes 2023
- Treatment of endometriomas: Surgical approaches and the impact on ovarian reserve, recurrence, and spontaneous pregnancy 2023
- Comparison of serum anti-Müllerian hormone between unilateral and bilateral ovarian endometriomas during follicular, luteal, and random menstrual phases: a retrospective study 2023
- Laparoscopic surgeries for uterine fibroids and ovarian cysts reduce ovarian reserve via age- and surgical type-manner 2022
- Serum anti-Müllerian hormone recovery after ovarian cystectomy for endometriosis: A retrospective study among Korean women 2022
- Endometriomas: the effectiveness of combination treatment 2021
- The Effects of Endometriosis on Ovarian Functions 2021
- Empirical and long-term therapy for endometriosis-associated pelvic pain 2021
- Ultrasound-guided sclerotherapy for the treatment of ovarian endometrioma: an updated systematic review and meta-analysis 2021
- Ovarian reserve after three‐step laparoscopic surgery for endometriomas utilizing dienogest: A pilot study 2020
SciLite annotations
chemicals 40
dienogest
dienogest
dienogest
dienogest
dienogest
dienogest
dienogest
dienogest
dienogest
progestin
progestin
dienogest
dienogest
estradiol
dienogest
progestin
dienogest
dienogest
progestin
progestin
dienogest
dienogest
dienogest
estrogen
progestin
dienogest
dienogest
dienogest
dienogest
dienogest
dienogest
progesterone
dienogest
dienogest
dienogest
dienogest
dienogest
dienogest
dienogest
progestin
organisms 10
noordeloos 2009062
noordeloos 2009062
noordeloos 2009062
noordeloos 2009062
noordeloos 2009062
noordeloos 2009062
noordeloos 2009062
noordeloos 2009062
human
human
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- scilite
- last seen: 2026-05-18T04:25:29.313245+00:00
License: CC0
· commercial use OK